JPMorgan Chase & Co’s PharmaCyte Biotech PMCB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16
| Closed | -$20 | – | 6506 |
|
|
2025
Q1 | $20 | Sell |
16
-2
| -11% | -$3 | ﹤0.01% | 6248 |
|
|
2024
Q4 | $28 | Hold |
18
| – | – | ﹤0.01% | 6176 |
|
|
2024
Q3 | $34 | Sell |
18
-1
| -5% | -$2 | ﹤0.01% | 6104 |
|
|
2024
Q2 | $37 | Buy |
19
+1
| +6% | +$2 | ﹤0.01% | 6052 |
|
|
2024
Q1 | $43 | Buy |
18
+6
| +50% | +$14 | ﹤0.01% | 6054 |
|
|
2023
Q4 | $26 | Sell |
12
-5
| -29% | -$11 | ﹤0.01% | 6263 |
|
|
2023
Q3 | $36 | Buy |
+17
| New | +$36 | ﹤0.01% | 6092 |
|
|
2022
Q2 | – | Sell |
-2,723
| Closed | -$6K | – | 5828 |
|
|
2022
Q1 | $6K | Buy |
+2,723
| New | +$6K | ﹤0.01% | 5472 |
|